Pediatr. praxi. 2007;8(6):394

Nové přípravky v léčbě rinosinusitid

doc. MUDr. Ludmila Vyhnánková CSc
ORL specialista, Praha

Sdělení pojednává o dvou nových lécích a jednom potravinovém doplňku, které jsou k dispozici v České republice. Je to Libenar f. GlaxoSmithKline, dále Olynth HA,0,1% f. Ursapharm a Nasivin Sinus – potravinový doplněk f. Merck. Je popsáno jejich složení, působení a indikace.

Published: January 20, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vyhnánková L. Nové přípravky v léčbě rinosinusitid. Pediatr. praxi. 2007;8(6):394.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pharmindex Brevíř, 2006, Medical Tribune, s. 858.
    2. Příbalový leták Libenar.
    3. Příbalový leták Nasivin Sinus.
    4. Příbalový leták Olynth HA 0,1%.
    5. Remedia Kompendium, 3. vydání, Panax Co, spol. s.r.o., kapitola 12.2: Léčiva používaná k terapii nemocí nosu a vedlejších nosních dutin, s. 585-591.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.